Transcept Pharmaceuticals (TSPT) Posts Wider than Expected Q2 Loss of 30c/Share

Transcept Pharmaceuticals, Inc. (NASDAQ: TSPT) reported Q2 EPS of ($0.30), $0.06 worse than the analyst estimate of ($0.24). Revenue for the quarter came in at $500 thousand versus the consensus estimate of $1.87 million.

For earnings history and earnings-related data on Transcept Pharmaceuticals, Inc. (TSPT) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Integer Holdings Corp (ITGR) Tops Q1 EPS by 2c ; Offers Guidance
• Independent Bank (IBCP) Tops Q1 EPS by 12c
• Netlist (NLST) Misses Q1 EPS by 1c